http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103864611-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-28 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-29 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate | 2013-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103864611-B |
| titleOfInvention | The preparation method of a kind of preparation method of Simvastatin alcohol acid compound, composition, composition and application thereof |
| abstract | The invention discloses a kind of preparation method of Simvastatin alcohol acid compound, this preparation method is simple, raw material is easy to get, and is conducive to suitability for industrialized production; The invention also discloses a kind of composition of Simvastatin alcohol acid compound, each auxiliary material component in said composition is easy to get, and is conducive to industrialization; The invention also discloses a kind of preparation method of composition of Simvastatin alcohol acid compound, this preparation method requires that processing condition are not high, easy to operate; The invention also discloses the application of a kind of Simvastatin alcohol acid compound in the medicine for the preparation for the treatment of hyperlipidemia, this Simvastatin alcohol acid compound toxicity significantly reduces, and does not need metabolism to be in vivo used for the treatment of hyperlipidemia. |
| priorityDate | 2013-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.